The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases

被引：24

作者：

Hu, LY ^{[1
]}

Boxer, PA ^{[1
]}

Kesten, SR ^{[1
]}

Lei, HSJ ^{[1
]}

Wustrow, DJ ^{[1
]}

Moreland, DW ^{[1
]}

Zhang, LM ^{[1
]}

Ahn, K ^{[1
]}

Ryder, TR ^{[1
]}

Liu, XH ^{[1
]}

Rubin, JR ^{[1
]}

Fahnoe, K ^{[1
]}

Carroll, RT ^{[1
]}

Dutta, S ^{[1
]}

Fahnoe, DC ^{[1
]}

Probert, AW ^{[1
]}

Roof, RL ^{[1
]}

Rafferty, MF ^{[1
]}

Kostlan, CR ^{[1
]}

Scholten, JD ^{[1
]}

Hood, M ^{[1
]}

Ren, XD ^{[1
]}

Schielke, GP ^{[1
]}

Su, TZ ^{[1
]}

Taylor, CP ^{[1
]}

Mistry, A ^{[1
]}

McConnell, P ^{[1
]}

Hasemann, C ^{[1
]}

Ohren, J ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Ann Arbor, MI USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 09期

关键词：

D O I：

10.1016/j.bmcl.2005.07.058

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The inhibition of the cytosolic isoenzyme BCAT that is expressed specifically in neuronal tissue is likely to be useful for the treatment of neurodegenerative and other neurological disorders where glutamatergic mechanisms are implicated. Compound 2 exhibited an IC50 of 0.8 mu M in the hBCATc assays; it is an active and selective inhibitor. Inhibitor 2 also blocked calcium influx into neuronal cells following inhibition of glutamate uptake, and demonstrated neuroprotective efficacy in vivo. SAR, pharmacology, and the crystal structure of hBCATc with inhibitor 2 are described. (C) 2005 Elsevier Ltd. All rights reserved.

引用

页码：2337 / 2340

页数：4

共 50 条

[41] Purification of branched-chain amino acid aminotransferase from Helicobacter pylori NCTC 11637
Saito, M.
Nishimura, K.
Wakabayashi, S.
Kurihara, T.
Nagata, Y.
AMINO ACIDS, 2007, 33 (03) : 445 - 449
[42] Branched-chain amino acids in liver diseases
Tajiri, Kazuto
Shimizu, Yukihiro
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
[43] Molecular model of human branched-chain amino acid metabolism
Suryawan, A
Hawes, JW
Harris, RA
Shimomura, Y
Jenkins, AE
Hutson, SM
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (01): : 72 - 81
[44] Eucalyptus ESTs associated with resistance to herbicide inhibitors of aromatic and branched-chain amino acid synthesis
Velini, Edivaldo Domingues
Bueno Trindade, Maria Lucia
Alves, Elza
Cataneo, Ana Catarina
Marino, Celso Luis
Maia, Ivan de Godoy
Mori, Edson Seizo
Furtado, Edson Luiz
Guerrini, Irae Amaral
Wilcken, Carlos Frederico
GENETICS AND MOLECULAR BIOLOGY, 2005, 28 (03) : 575 - 581
[45] Branched-chain amino acid treatment in patients with liver cirrhosis
Suzuki, K
Kato, A
Iwai, M
HEPATOLOGY RESEARCH, 2004, 30 : S25 - S29
[46] The effect of branched-chain amino acid supplementation on cancer treatment
Lee, Kassidy
Blanton, Cynthia
NUTRITION AND HEALTH, 2023, 29 (04) : 621 - 635
[47] COMPARTMENTATION AND ACTIVITY OF BRANCHED-CHAIN L-AMINO-ACID AMINOTRANSFERASE (EC 2.6.1.42) IN HUMAN-FIBROBLASTS
SCHADEWALDT, P
HAMMEN, HW
WENDEL, U
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (09): : 904 - 904
[48] Branched-chain amino acids and neurotransmitter metabolism: Expression of cytosolic branched-chain aminotransferase (BCATc) in the cerebellum and hippocampus
Sweatt, AJ
Garcia-Espinosa, MA
Wallin, R
Hutson, SM
JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 477 (04) : 360 - 370
[49] IDENTIFICATION OF THE MITOCHONDRIAL BRANCHED-CHAIN AMINOTRANSFERASE AS A BRANCHED-CHAIN ALPHA-KETO ACID TRANSPORT PROTEIN
HUTSON, SM
HALL, TR
JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (05) : 3084 - 3091
[50] IS THE MITOCHONDRIAL BRANCHED-CHAIN AMINOTRANSFERASE (BCAT(M)) THE BRANCHED-CHAIN ALPHA-KETO ACID TRANSPORTER
TORRES, N
LI, L
HUTSON, SM
FASEB JOURNAL, 1993, 7 (07): : A1145 - A1145

← 1 2 3 4 5 →